Pharmacotherapy for Postprandial Hyperglycemia in Type 2 Diabetes / 임상당뇨병
Journal of Korean Diabetes
;
: 39-43, 2012.
Artículo
en Coreano
| WPRIM
| ID: wpr-726818
ABSTRACT
A growing body of evidence shows that effective postprandial hyperglycemia management in individuals with type 2 diabetes can reduce the risk of diabetic complications and cardiovascular diseases. Therefore, accurate monitoring and effective intervention for postprandial hyperglycemia is very important in routine clinical practice for type 2 diabetes. Therapeutic modalities for the management of postprandial hyperglycemia include oral antidiabetic drugs (alpha glucosidase inhibitor, meglitinide, dipeptidyl peptidase-IV inhibitor), ultra-short-acting insulin analogues, and incretin mimetics. A detailed understanding of the advantages and disadvantages of various pharmacotherapies and a careful understanding of the underlying physical and social situations of each patient will be of great help to determine the appropriate prescription for postprandial hyperglycemia management.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Benzamidas
/
Enfermedades Cardiovasculares
/
Complicaciones de la Diabetes
/
Diabetes Mellitus Tipo 2
/
Incretinas
/
Prescripciones
/
Glucosidasas
/
Hiperglucemia
/
Hipoglucemiantes
/
Insulina
Límite:
Humanos
Idioma:
Coreano
Revista:
Journal of Korean Diabetes
Año:
2012
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS